Clinical Trial Update: Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Ferumoxtran-10–enhanced MRI in prostate cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ferumoxtran-10 (ferumoxtran-10)

Snippet

Sponsor: Saving Patients' Lives Medical B.V. | Conditions: Prostate Cancer, Metastasis | Phase 3 | Status: TERMINATED